rhinoplasty.cc
Menu

Journal archive · 2025

PRS Plastic and Reconstructive Surgery · 2025

Dispelling the Myths of Isotretinoin and Implications for Rhinoplasty

Blough JT, Rohrich RN, Wyles SP, Rohrich RJ.

What this paper says

Reviewing 49 studies, the authors conclude that oral isotretinoin is safe around most surgery and may be useful in selected rhinoplasty patients to thin thick skin and reduce internal scarring.

Overview

Concerns about isotretinoin, a vitamin A derivative used for acne, date from case reports in the 1980s that linked it to poor healing. The authors reviewed the evidence and state it has largely proven safe in surgical procedures, with deep skin resurfacing the exception. They then examine its therapeutic potential in rhinoplasty, where thinning the skin and limiting internal scarring could improve definition.

Sections of note

  • Design: review of 49 studies of patients undergoing surgery while taking isotretinoin.
  • Stated finding: isotretinoin use appears safe across a wide variety of procedures that rely on internal scar formation.
  • Stated exception: deep skin resurfacing.
  • In rhinoplasty, oral isotretinoin was used to thin the skin and improve appearance, with reported patient and surgeon satisfaction.
  • Candidates identified: patients with thick, hairless, oily skin; male patients; certain races or ethnicities; and revision cases.
  • The authors state further studies are needed on optimal dosing and long term benefits.
  • No patient numbers, doses, complication rates or outcome measures appear in the abstract.

What it means for a patient

  • Thick oily skin masks the refinements made beneath it, which is why thinning it is proposed as an aid to the surgical result.
  • The long standing advice to stop isotretinoin before surgery is challenged here for most procedures, though deep resurfacing remains an exception.
  • Isotretinoin has significant side effects and is strictly avoided in pregnancy, none of which the abstract discusses.
  • The abstract carries no findings on rhinoplasty specifically. There are no doses, patient numbers or measured outcomes.

Why this paper matters

Thick skin is one of the strongest limits on what rhinoplasty can achieve, and no established medical treatment addresses it. Reframing a widely avoided drug as a potential tool would open a route surgeons currently lack. Dosing, timing and whether it measurably improves results remain unanswered.

Terms

  • Isotretinoin: an oral vitamin A derivative used to treat severe acne.
  • Sebaceous skin: skin with abundant oil glands, typically thicker.
  • Glabrous: hairless skin.
  • Skin resurfacing: treatment removing the outer skin layers, by laser or chemical peel.
  • Internal scarring: scar tissue forming beneath the skin rather than on the surface.
  • Revision case: an operation performed to correct the result of an earlier one.

Summary written by rhinoplasty.cc from the abstract, 2026-09-09; not medical advice. The authors' own abstract follows.

From the abstract

“Despite concerns from 1980s case reports, oral isotretinoin, a derivative of vitamin A, has largely proven to be safe in surgical procedures, with the exception of deep skin resurfacing. Isotretinoin modulates thinning skin and internal scarring in select rhinoplasty patients who may otherwise have poor definition and…”

Excerpt; the full abstract is on PubMed.

Citation

PubMed
Journal
Plastic and Reconstructive Surgery
Year
2025
Authors
4
Type
Journal Article, Review
Access
Subscription
On this site
Summary and abstract

Authors on this site

Start here

This paper sits outside the 16 topic groups; the archive holds every paper by journal and year.

Related papers

Same journal, 2025.

  1. PRS
    2025PMID 41071182Summary
  2. PRS
    2025PMID 39965161Summary
  3. PRS
    2025PMID 41071223Summary
  4. PRS
    2025PMID 39026386Summary
  5. PRS
    2025PMID 38589989Summary
  6. PRS
    2025PMID 38780387Summary
  7. PRS
    2025PMID 40865067
  8. PRS
    2025PMID 39999233